Perimenopause and Tendon Pain: What the Evidence Actually Says About Estrogen, Collagen, and Your Achilles at 49

Did perimenopause cause your Achilles pain?

You are 49, you have not changed your running volume, and suddenly your Achilles is stiff every morning and sore on the first mile. It is a reasonable question to ask whether the hormonal transition you are in is responsible. The honest answer is: possibly as a contributing factor, but the evidence is contradictory and low-level, and — this is the part that matters — the answer does not change the training plan.

That is not a dodge. It is the most useful thing this article can tell you. The clinically actionable question is not are my hormones to blame? It is what loading can this tendon tolerate this week, and how do I know? Those two questions are separable, and the second one is the one you can act on with a resistance band, a bathroom scale, a stopwatch, and a tape measure.

What the tendon-hormone evidence actually shows

The most direct synthesis on this topic is a systematic review of female sex hormone supplementation and tendon outcomes in pre- and postmenopausal women (Ganderton et al., Journal of Musculoskeletal and Neuronal Interactions, 2016). Its findings are worth quoting precisely because they are so much less dramatic than the internet version:

“Low level of evidence for all outcomes; no positive or negative link between FSHS and molecular, mechanical and morphological tendon response outcomes, and the addition of exercise to FSHS, had minimal effects on tendon CSA.”

The authors concluded that “the effect of oestrogen supplementation on tendon is contradictory and inconsistent.” That is the state of the evidence. Not estrogen protects tendons, not estrogen loss destroys tendons — contradictory and inconsistent, at low level of evidence.

This matters because the popular story — estrogen drops, collagen collapses, tendon ruptures — is a chain of claims that the review does not support as a causal sequence. The review does note, as background cited in the literature, that declining estrogen after menopause has been associated with reduced collagen production and thinner tendons, and with higher rates of tendon pathology and rupture. But it presents those as claims from other sources, not as its own finding, and it simultaneously reports that the effect of estrogen on collagen turnover varies across studies, with some finding inhibition, some no effect, and some stimulation.

In other words: the biology is plausible, the clinical picture is muddy, and anyone who tells you they know exactly how your hormones are affecting your Achilles is overreaching.

Why the research is muddy — and why that is not your problem to solve

Part of the reason the evidence is inconsistent is that tendon research has historically neglected sex as a variable. A 2022 systematic review of preclinical tendinopathy treatment studies (Biology of Sex Differences) analyzed 150 studies covering 8,231 animals and found that none analyzed sex-based differences, and only 4% reported data disaggregated by sex. The same review’s highlights state that tendinopathy has sex-specific features, with sex hormones affecting tendon metabolism, structure, biomechanical properties, and injury risk — but the preclinical pipeline has largely failed to study that properly.

So you have a situation where the mechanism is widely acknowledged and the treatment evidence is thin. That is a research problem. It is not a reason for you to wait for better data before loading your tendon, because the loading evidence — while not specific to perimenopausal Achilles — is considerably more actionable.

The one trial worth knowing

The most relevant randomized trial for this population is not about the Achilles. It is about gluteal tendinopathy in postmenopausal women with greater trochanteric pain syndrome (GTPS), published in 2021 (PubMed 34898293). It is worth understanding because of what it did and did not find.

One hundred and thirty-two postmenopausal women were randomized into menopausal hormone therapy (MHT) or placebo transdermal cream groups, combined with either tendon-specific exercise or sham exercise. All groups received education about avoiding gluteal tendon compression and load management, for 12 weeks.

The results:

  • All groups improved over time, at 12 weeks and at 52 weeks.
  • There was no difference among exercise groups on any outcome. The tendon-specific exercise and the sham exercise performed similarly.
  • MHT groups with exercise and education had significantly better VISA-G scores than placebo at all time points — but only in the subgroup with BMI under 25.

The authors concluded that “a targeted exercise or sham exercise strategy is effective when prescribed with education about avoiding gluteal tendon compression and load management.”

What this licenses: exercise plus load-management education is a reasonable core strategy for postmenopausal women with tendon pain, and the specific exercise selection may matter less than the loading context and education. What it does not license: any claim that this trial validates a protocol for Achilles tendinopathy, that MHT will fix your tendon, or that the BMI finding generalizes to you. The trial tested a different tendon, a different exercise prescription, and a hormonal intervention that is a clinical decision, not a training decision.

The practical translation: build the plan around load, not hormones

If the trial’s most robust signal is that exercise plus load-management education helped regardless of exercise type, then the self-directed adult’s job is to manage load intelligently and progress on criteria. Hormonal status is a context variable, not a training variable. Here is a phase-based framework you can run at home or in a gym. It is an illustrative framework built from the principles above, not a validated protocol for perimenopausal Achilles pain.

Phase 1 — Calm the tendon (roughly 1–2 weeks, or until morning stiffness settles)

The goal here is not to strengthen; it is to reduce the irritability that makes every step feel like a negotiation. Isometric loading is a common entry point because it allows meaningful force with minimal movement.

Example protocol (illustrative):

  • Seated or standing calf isometric hold: push through the ball of the foot against the floor or a fixed surface. Build to roughly 70% of what you could maximally hold. Hold 30–45 seconds. Rest 60 seconds. 5 repetitions. Once or twice daily.
  • Load quantification with a bathroom scale: stand with the affected foot on the scale and the other foot on a book of similar height. Shift weight until the scale reads a target — for example, 50% of body weight for the affected side. Hold 30 seconds. This gives you a number to progress, rather than a vague sense of “pushing fairly hard.”
  • Pain-monitoring rule: keep pain during loading at or below 3/10 on a simple 0–10 scale, and no worse the following morning. If morning stiffness increases and persists beyond 30 minutes, the previous day’s load was too high.

Use a stopwatch for holds and rests. The scale and stopwatch turn a fuzzy intervention into something you can actually titrate.

Phase 2 — Build capacity (roughly 6–12 weeks, progressed on criteria)

Once morning stiffness is stable and isometric loading is tolerated, move to progressive resistance through range. For the Achilles, that means heel raises — the classic loaded calf exercise — performed with enough load and range to drive adaptation.

Example protocol (illustrative):

  • Standing heel raise, both legs: 3 sets of 10–15 repetitions, rising over 2 seconds and lowering over 3 seconds. Body weight first; add a backpack with books when 15 repetitions are comfortable.
  • Single-leg heel raise: 3 sets of 8–12 repetitions, same tempo. This is the workhorse. Progress load by adding weight to the backpack in 2–5% increments.
  • Frequency: 3–4 times per week, with at least one rest day between sessions.
  • Progression criteria: increase load only when you can complete all prescribed sets and reps with pain ≤3/10 during the session and no increase in morning stiffness the next day, for two consecutive sessions.

Track your heel-raise height with a tape measure — mark the wall or use a step — because range of motion often improves before strength does, and it is a useful secondary signal that the tendon is tolerating load.

Phase 3 — Return to demand (variable, criteria-based)

This is where you reintroduce the activity that provoked the pain — running, hiking, court sports — in a graded way. The principle is to add demand in small increments and use your pain-monitoring rule as a gate.

Example progression (illustrative):

  • Start with walk-run intervals: 1 minute running, 2 minutes walking, repeated 8 times, every other day.
  • Increase running time by no more than 10% per week, provided pain stays ≤3/10 during and morning stiffness does not increase.
  • Keep Phase 2 strength work at maintenance volume (2 sessions per week) throughout.

Use the stopwatch to time intervals and the tape measure to check that calf range is holding. If morning stiffness climbs, drop back one step for a week rather than pushing through.

What to track, and when to get help

A simple log — date, exercise, load, pain during, pain next morning, morning stiffness duration — is enough. Bring it to a clinician if you need to. The pattern matters more than any single number.

Seek clinical assessment rather than self-managing if you have: sudden severe pain or a snap in the calf, inability to bear weight, swelling or redness that is worsening, pain that is waking you at night and not settling, or no improvement after 6–8 weeks of consistent criteria-based loading. Hormonal questions — whether MHT is appropriate for you, what your perimenopausal status means for your overall health — belong with a clinician who knows your history. This article cannot answer those, and it should not pretend to.

The bottom line

The evidence does not support a clean story in which perimenopause causes Achilles pain through an estrogen-collagen mechanism. It supports a messier story: sex hormones probably matter to tendon biology, the treatment evidence is contradictory and low-level, and the most useful trial in postmenopausal women found that exercise plus load-management education helped regardless of whether the exercise was tendon-specific.

That means your plan is the same whether or not hormones are involved. Calm the tendon, build capacity, return to demand, and progress on criteria you can measure with a scale, a stopwatch, and a tape measure. The hormonal question is real, and it is worth asking your clinician. But it is not the question that determines whether your Achilles gets better.

FAQ

Does hormone replacement therapy prevent or treat Achilles tendon pain?

The evidence does not support that claim. The systematic review found contradictory and inconsistent effects of hormone supplementation on tendon outcomes, at low level of evidence. The GTPS trial found a benefit of MHT in a BMI-restricted subgroup, but that was for gluteal tendinopathy, not Achilles, and it does not establish a general preventive or treatment effect. MHT is a clinical decision to discuss with your doctor, not a tendon treatment you can self-prescribe.

Should I take collagen for my tendon?

This article does not make a recommendation for or against collagen supplementation, because the evidence brief for this piece did not include collagen supplementation trials. The loading protocol above does not depend on it. If you are considering it, treat it as a separate question to raise with a clinician or dietitian rather than as a substitute for progressive loading.

How do I know if I am progressing too fast?

Use the pain-monitoring rule: pain during loading at or below 3/10, and no increase in morning stiffness the next day. If morning stiffness increases and lasts longer than 30 minutes, or pain during loading exceeds 3/10, reduce load by roughly 10–20% and hold for a week before progressing again. The scale and stopwatch make this concrete rather than guesswork.

Is it normal for tendons to hurt more in perimenopause?

It is commonly reported, and the biological rationale is plausible, but the evidence does not establish perimenopause as a cause of tendon pain. Treat the hormonal transition as context, not as a diagnosis. If pain is new, severe, or not improving with sensible loading, get it assessed.